The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.
about
Pneumococcal vaccine for preventing Streptococcus pneumoniae infection in HIV-infected individualsBacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort studyEvaluation of respiratory diseasePersistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment programEffectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control studyAIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy.Pneumococcal vaccine and HIV infection: report of a vaccine failure and reappraisal of its value in clinical practiceEpidemiology of pneumococcal disease in a national cohort of older adultsThe association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.Acquired disorders of phagocyte function complicating medical and surgical illnesses.Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.Patients with HIV infection and fever: a diagnostic approach.Pneumococcal septic arthritis: review of 190 cases.Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharidesImmune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.CD8+ T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected womenBacterial infections in adult HIV-infected patients.Should patients positive for HIV infection receive pneumococcal vaccine?Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival.Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.Increased prevalence of HIV-2 infection in hospitalized patients with severe bacterial diseases in Guinea-Bissau.Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model.HIV induces both a down-regulation of IRAK-4 that impairs TLR signalling and an up-regulation of the antibiotic peptide dermcidin in monocytic cells.Pneumococcal virulence factors and host immune responses to them.Recurrent Streptococcus pneumoniae endocarditis.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses.Immunization of HIV-infected adult patients - French recommendations.Bacterial pneumonia. S pneumoniae and H influenzae are the villains.Antibody Response is More Likely to Pneumococcal Proteins Than to Polysaccharide After HIV-associated Invasive Pneumococcal Disease.Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study.Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade.COMMUNITY ACQUIRED PNEUMOCOCCAL PNEUMONIA IN NORTHWESTERN NIGERIA: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE AND OUTCOME.Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community.
P2860
Q24186767-DD8F7D7F-8D98-4950-AF6E-AAEE0B07B792Q24806095-7F9E899D-7E0B-4540-B184-4DEB687B1B45Q26828791-1BA853B9-A500-41D4-A7FC-AE2703E086F0Q28742203-6D16E90A-0046-4139-A1D7-78E063FAD51CQ33303633-374B29A2-5788-4938-ADBE-6201915BA2FBQ33604838-1988BDA7-7C71-4F6F-9E5E-E74D8D70CCF7Q33781248-1FF0BE71-A046-41FE-AC73-6F951F5D277BQ33935513-57737268-7CA4-465A-9C40-1E666640B2CDQ33939120-577E1600-AA40-4DB3-9C56-92EB2D651971Q34311579-D04DA8F6-3B32-42F5-A788-810F58074E9EQ34431379-D062E7D0-055C-49C4-A292-5B7B8D056B8DQ34452479-530723A6-B5C9-460E-85F2-CA7E9974DDEFQ35014909-96845414-098E-4A3F-BBE8-A51CBBD599E2Q35049965-519DC1BF-5D9C-438B-A1C4-819AAE574A47Q35139987-CCFE6319-D644-4E77-9E6C-0A8C676E641AQ35874108-9356EEE8-87BF-4FEE-A47E-C1DA5F5390C9Q35989605-6A7E8AE1-7F26-438A-B82C-73B8716A8F0EQ36281588-F6215613-334D-4C5C-9D28-9C52FBA4FD71Q36903279-4E580A60-146F-4BEE-80EA-7D01F4EFC3F3Q37347389-4EA02003-BA54-42D4-8B4A-E5C8CD144BA4Q38419709-E4D7D375-651A-4CBC-B694-71727F9E3976Q38493980-D0A22E0F-F523-495C-8F47-EC831B47869AQ38639401-50AF5F30-8AD2-4FD2-A408-53B2A61668B5Q39309480-4D159C83-335E-4194-8136-0C0BAD815081Q39392994-E63F6B86-4079-481D-ABEC-D85125B6B549Q39809074-3503836F-E95B-450A-91D8-B703190B359DQ40432501-2D6EC9A1-B710-47B6-8132-4B0B93E931E3Q40432510-F81BCFD1-5CB6-4C39-8969-042A3C5D6F1FQ40560650-DD45BF43-C8D5-4D03-A849-667E9162F913Q40588212-2D1BCAD3-BB77-430A-97C3-5A07AE86B2BAQ40615516-A5D75A97-2CC8-4CA4-AA94-2918B72D8154Q40907073-447DECFB-12A7-4557-97C4-C036A5CDB3D4Q41436543-2BBF80EC-0BEE-425A-874B-3FADB57B2D1BQ42221844-BAD24883-1ECE-4259-B3A3-2C49A0FEC6C7Q43000726-97322082-617C-4C06-81F3-11F02C2007A1Q43712235-F0B6F649-71B4-4FCA-95A5-28B425BBCF5BQ43926822-4BEBAB28-B766-4BE1-B815-558253D5427AQ44384230-DB8AAF73-DB0A-4C14-B701-8D3E0BCE8BC2Q47158475-0F584061-68E8-4349-82FE-D1E06D58321FQ53963571-A675A22F-A9A4-4DB5-B8BB-647D599472E0
P2860
The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
The role of human immunodefici ...... ia in San Francisco residents.
@en
The role of human immunodefici ...... ia in San Francisco residents.
@nl
type
label
The role of human immunodefici ...... ia in San Francisco residents.
@en
The role of human immunodefici ...... ia in San Francisco residents.
@nl
prefLabel
The role of human immunodefici ...... ia in San Francisco residents.
@en
The role of human immunodefici ...... ia in San Francisco residents.
@nl
P2093
P356
P1476
The role of human immunodefici ...... ia in San Francisco residents.
@en
P2093
Facklam RR
Rutherford GW 3rd
P304
P356
10.1093/INFDIS/162.5.1012
P407
P577
1990-11-01T00:00:00Z